2 results
Approved WMOCompleted
To evaluate BlueWind Medical RENOVATM System safety and performance in OAB patients for extended FU period of 36 months.
Approved WMORecruiting
To find a simple test to explain non-responsiveness to sumatriptan in a proportion of patients with migraine.